Report Summary
Eternity Insights has published a new study on Global Gene Editing Market focusing on key segments as by Type (Clustered Regularly Interspaced Short Palindromic Repeats, Transcription Activator-like Effector Nucleases (TALEN), Zinc-finger Nucleases (ZFNs), Homing Endonucleases or Meganucleases), by Application (Biotechnology Industry, Horticulture Industry, Animal Breeding, Academic and Research Institutes), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Gene Editing Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Gene Editing Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Gene Editing Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Gene Editing Market Segmentation:
Gene Editing Market, By Type
- Clustered Regularly Interspaced Short Palindromic Repeats
- Transcription Activator-like Effector Nucleases (TALEN)
- Zinc-finger Nucleases (ZFNs)
- Homing Endonucleases or Meganucleases
Gene Editing Market, By Application
- Biotechnology Industry
- Horticulture Industry
- Animal Breeding
- Academic and Research Institutes
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Gene Editing market in terms of demand generation. The Gene Editing market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Gene Editing market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Gene Editing Market Taxonomy:
To learn more about this report
Global Gene Editing Market Competitive Landscape
The global Gene Editing market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- RGen Solutions
- New England Biolabs Inc
- GeneCopoeia
- Inc.
- Genscript Biotech Corporation
- OriGene Technologies
- Inc.
- Agilent Technologies
- Lonza Group
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
Report Attributes |
Details |
The market size value in 2021 |
USD XX.XX Million |
CAGR (2021 - 2028) |
XX.XX % |
The Revenue forecast in 2028 |
USD XX.XX Million |
Base year for estimation |
2021 |
Historical data |
2018-2019 |
Forecast period |
2022-2028 |
Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
By Type Outlook |
Clustered Regularly Interspaced Short Palindromic Repeats, Transcription Activator-like Effector Nucleases (TALEN), Zinc-finger Nucleases (ZFNs), Homing Endonucleases or Meganucleases |
By Application Outlook |
Biotechnology Industry, Horticulture Industry, Animal Breeding, Academic and Research Institutes |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
Key companies profiled |
RGen Solutions, New England Biolabs Inc, GeneCopoeia, Inc., Genscript Biotech Corporation, OriGene Technologies, Inc., Agilent Technologies, Lonza Group |
Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Gene Editing Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Gene Editing Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Product Type Market
2.1 World Product Type Market Performance and Trend
2.1.1 World Market Performance
2.1.2 Different Type of Market Performance
2.2 North America Product Type Market Performance and Trend
2.2.1 North America Market Performance
2.2.2 Different Type of Market Performance
2.3 Europe Product Type Market Performance and Trend
2.3.1 Europe Market Performance
2.3.2 Different Type of Market Performance
2.4 Asia-Pacific Product Type Market Performance and Trend
2.4.1 Asia-Pacific Market Performance
2.4.2 Different Type of Market Performance
2.5 South America Product Type Market Performance and Trend
2.5.1 South America Market Performance
2.5.2 Different Type of Market Performance
2.6 Middle East and Africa Product Type Market Performance and Trend
2.6.1 Middle East and Africa Market Performance
2.6.2 Different Type of Market Performance
3 Product Application Market
3.1 World Product Application Market Performance and Trend
3.1.1 World Market Performance
3.1.2 Different Applications of Market Trend
3.2 North America Product Application Market Performance and Trend
3.2.1 North America Market Performance
3.2.2 Different Applications of Market Trend
3.3 Europe Product Application Market Performance and Trend
3.3.1 Europe Market Performance
3.3.2 Different Applications of Market Trend
3.4 Asia-Pacific Product Application Market Performance and Trend
3.4.1 Asia-Pacific Market Performance
3.4.2 Different Applications of Market Trend
3.5 South America Product Application Market Performance and Trend
3.5.1 South America Market Performance
3.5.2 Different Applications of Market Trend
3.6 Middle East and Africa Product Application Market Performance and Trend
3.6.1 Middle East and Africa Market Performance
3.6.2 Different Applications of Market Trend
4 Manufacturers Profiles/Analysis
4.1 RGen Solutions
4.1.1 RGen Solutions Profiles
4.1.2 RGen Solutions Product Information
4.1.3 RGen Solutions Gene Editing Business Performance
4.1.4 RGen Solutions Gene Editing Business Development and Market Status
4.2 New England Biolabs Inc
4.2.1 New England Biolabs Inc Profiles
4.2.2 New England Biolabs Inc Product Information
4.2.3 New England Biolabs Inc Gene Editing Business Performance
4.2.4 New England Biolabs Inc Gene Editing Business Development and Market Status
4.3 GeneCopoeia, Inc.
4.3.1 GeneCopoeia, Inc. Profiles
4.3.2 GeneCopoeia, Inc. Product Information
4.3.3 GeneCopoeia, Inc. Gene Editing Business Performance
4.3.4 GeneCopoeia, Inc. Gene Editing Business Development and Market Status
4.4 Genscript Biotech Corporation
4.4.1 Genscript Biotech Corporation Profiles
4.4.2 Genscript Biotech Corporation Product Information
4.4.3 Genscript Biotech Corporation Gene Editing Business Performance
4.4.4 Genscript Biotech Corporation Gene Editing Business Development and Market Status
4.5 OriGene Technologies, Inc.
4.5.1 OriGene Technologies, Inc. Profiles
4.5.2 OriGene Technologies, Inc. Product Information
4.5.3 OriGene Technologies, Inc. Gene Editing Business Performance
4.5.4 OriGene Technologies, Inc. Gene Editing Business Development and Market Status
4.6 Agilent Technologies
4.6.1 Agilent Technologies Profiles
4.6.2 Agilent Technologies Product Information
4.6.3 Agilent Technologies Gene Editing Business Performance
4.6.4 Agilent Technologies Gene Editing Business Development and Market Status
4.7 Lonza Group
4.7.1 Lonza Group Profiles
4.7.2 Lonza Group Product Information
4.7.3 Lonza Group Gene Editing Business Performance
4.7.4 Lonza Group Gene Editing Business Development and Market Status
5 Market Performance for Manufacturers
5.1 Global Gene Editing Sales (K Units) and Market Share by Manufacturers 2014-2019
5.2 Global Gene Editing Revenue (M USD) and Market Share by Manufacturers 2014-2019
5.3 Global Gene Editing Price (USD/Unit) of Manufacturers 2014-2019
5.4 Global Gene Editing Gross Margin of Manufacturers 2014-2019
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 North America Market Performance for Manufacturers
6.1.1 North America Gene Editing Sales (K Units) and Share of Manufacturers 2014-2019
6.1.2 North America Gene Editing Revenue (M USD) and Share of Manufacturers 2014-2019
6.1.3 North America Gene Editing Price (USD/Unit) of Manufacturers 2014-2019
6.1.4 North America Gene Editing Gross Margin of Manufacturers 2014-2019
6.1.5 Market Concentration
6.2 Europe Market Performance for Manufacturers
6.2.1 Europe Gene Editing Sales (K Units) and Share of Manufacturers 2014-2019
6.2.2 Europe Gene Editing Revenue (M USD) and Share of Manufacturers 2014-2019
6.2.3 Europe Gene Editing Price (USD/Unit) of Manufacturers 2014-2019
6.2.4 Europe Gene Editing Gross Margin of Manufacturers 2014-2019
6.2.5 Market Concentration
6.3 Asia-Pacific Market Performance for Manufacturers
6.3.1 Asia-Pacific Gene Editing Sales (K Units) and Share of Manufacturers 2014-2019
6.3.2 Asia-Pacific Gene Editing Revenue (M USD) and Share of Manufacturers 2014-2019
6.3.3 Asia-Pacific Gene Editing Price (USD/Unit) of Manufacturers 2014-2019
6.3.4 Asia-Pacific Gene Editing Gross Margin of Manufacturers 2014-2019
6.3.5 Market Concentration
6.4 South America Market Performance for Manufacturers
6.4.1 South America Gene Editing Sales (K Units) and Share of Manufacturers 2014-2019
6.4.2 South America Gene Editing Revenue (M USD) and Share of Manufacturers 2014-2019
6.4.3 South America Gene Editing Price (USD/Unit) of Manufacturers 2014-2019
6.4.4 South America Gene Editing Gross Margin of Manufacturers 2014-2019
6.4.5 Market Concentration
6.5 Middle East and Africa Market Performance for Manufacturers
6.5.1 Middle East and Africa Gene Editing Sales (K Units) and Share of Manufacturers 2014-2019
6.5.2 Middle East and Africa Gene Editing Revenue (M USD) and Share of Manufacturers 2014-2019
6.5.3 Middle East and Africa Gene Editing Price (USD/Unit) of Manufacturers 2014-2019
6.5.4 Middle East and Africa Gene Editing Gross Margin of Manufacturers 2014-2019
6.5.5 Market Concentration
7 World Market Performance Point
7.1 World Gene Editing Sales (K Units) and Share by Regions and Countries 2014-2019
7.1.1 World Gene Editing Sales (K Units) and Share by Regions 2014-2019
7.1.2 Regional Sales (K Units) and Share by Countries 2014-2019
7.1.2.1 Asia-Pacific Gene Editing Sales (K Units) and Share by Countries 2014-2019
7.1.2.2 North America Gene Editing Sales (K Units) and Share by Countries 2014-2019
7.1.2.3 Europe Gene Editing Sales (K Units) and Share by Countries 2014-2019
7.1.2.4 South America Gene Editing Sales (K Units) and Share by Countries 2014-2019
7.1.2.5 Middle East and Africa Gene Editing Sales (K Units) and Share by Countries 2014-2019
7.2 World Revenue (M USD) and Share by Regions and Countries 2014-2019
7.2.1 World Revenue (M USD) and Share by Regions 2014-2019
7.2.2 Regional Revenue (M USD) and Share by Countries 2014-2019
7.2.2.1 Asia-Pacific Gene Editing Revenue (M USD) and Share by Countries 2014-2019
7.2.2.2 North America Gene Editing Revenue (M USD) and Share by Countries 2014-2019
7.2.2.3 Europe Gene Editing Revenue (M USD) and Share by Countries 2014-2019
7.2.2.4 South America Gene Editing Revenue (M USD) and Share by Countries 2014-2019
7.2.2.5 Middle East and Africa Gene Editing Revenue (M USD) and Share by Countries 2014-2019
7.3 World Price (USD/Unit) by Regions and Countries 2014-2019
7.3.1 World Price (USD/Unit) by Regions 2014-2019
7.3.2 Regional Price (USD/Unit) by Countries 2014-2019
7.3.2.1 Asia-Pacific Gene Editing Price (USD/Unit) by Countries 2014-2019
7.3.2.2 North America Gene Editing Price (USD/Unit) by Countries 2014-2019
7.3.2.3 Europe Gene Editing Price (USD/Unit) by Countries 2014-2019
7.3.2.4 South America Gene Editing Price (USD/Unit) by Countries 2014-2019
7.3.2.5 Middle East and Africa Gene Editing Price (USD/Unit) by Countries 2014-2019
7.4 World Gross Margin by Regions and Countries 2014-2019
7.4.1 World Gross Margin by Regions 2014-2019
7.4.2 Regional Gross Margin and Share by Countries 2014-2019
7.4.2.1 Asia-Pacific Gene Editing Gross Margin and Share by Countries 2014-2019
7.4.2.2 North America Gene Editing Gross Margin and Share by Countries 2014-2019
7.4.2.3 Europe Gene Editing Gross Margin and Share by Countries 2014-2019
7.4.2.4 South America Gene Editing Gross Margin and Share by Countries 2014-2019
7.4.2.5 Middle East and Africa Gene Editing Gross Margin and Share by Countries 2014-2019
8 Development Trend for Regions and Countries (Sales Point)
8.1 World Gene Editing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3 North America Gene Editing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4 Europe Gene Editing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5 South America Gene Editing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6 Middle East and Africa Gene Editing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Biotechnology Industry Industry
11.2 Horticulture Industry Industry
11.3 Animal Breeding Industry
11.4 Academic and Research Institutes Industry
12 Market Forecast 2020-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2020-2026
12.1.1 Global Gene Editing Sales (K Units), Revenue (M USD) and Market Share by Regions 2020-2026
12.1.2 Global Gene Editing Sales (K Units) and Growth Rate 2020-2026
12.1.3 Asia-Pacific Gene Editing Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.1.4 North America Gene Editing Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.1.5 Europe Gene Editing Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.1.6 South America Gene Editing Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.1.7 Middle East and Africa Gene Editing Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.2 World Gene Editing Sales (K Units) and Revenue (M USD) Forecast by Types 2020-2026
12.2.1 Overall Market Performance
12.2.2 Clustered Regularly Interspaced Short Palindromic Repeats Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.2.3 Transcription Activator-like Effector Nucleases (TALEN) Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.2.4 Zinc-finger Nucleases (ZFNs) Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.2.5 Homing Endonucleases or Meganucleases Sales (K Units), Revenue (M USD) and Growth Rate 2020-2026
12.3 World Gene Editing Market Forecast by Application 2020-2026
12.3.1 Overall Market Performance
12.3.2 Biotechnology Industry Sales and and Growth Rate 2020-2026
12.3.3 Horticulture Industry Sales and and Growth Rate 2020-2026
12.3.4 Animal Breeding Sales and and Growth Rate 2020-2026
12.3.5 Academic and Research Institutes Sales and and Growth Rate 2020-2026
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Global Gene Editing Price (USD/Unit) Trend 2020-2026
12.4.2 Global Gene Editing Gross Profit Trend 2020-2026
13 Conclusion